SCHEMBL4012673

SCHEMBL4012673

O=C(O)CCc1c(O)cccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.52
FFAR1 O14842 4/20 0.48
GPR17 Q13304 3/20 0.46
AKR1B1 P15121 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
HDAC3 O15379 1/20 0.43
MAPK1 P28482 1/20 0.43
ADRA1A P35348 1/20 0.43
HDAC4 P56524 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HDAC1 Q13547 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31086284 0.88 IAPP (0.49) KEAP1FFAR1GPR17AKR1B1
SCHEMBL28822315 0.86 FFAR1 (0.49) KEAP1FFAR1GPR17AKR1B1SMN1; SMN2
SCHEMBL28677666 0.86 GPR17 (0.55) KEAP1FFAR1GPR17AKR1B1HDAC3
SCHEMBL29985739 0.84 MAPT (0.58) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL3432505 0.83 ERN1 (0.48) KEAP1FFAR1GPR17CA1CA2
SCHEMBL26046345 0.81 IAPP (0.46) KEAP1FFAR1AKR1B1
SCHEMBL1607606 0.79 IAPP (0.50) FFAR1AKR1B1
SCHEMBL2982550 0.78 CA1 (0.41) AKR1B1CA12CA1CA2CA7
Azelaic Acid SCHEMBL28605695 0.78 MAPT (0.66) KEAP1FFAR1HDAC3MAPK1ADRA1A
SCHEMBL10782682 0.77 HSD17B10 (0.50) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117586497-B Preparation method of printing ink based on amino-terminated hyperbranched polyamide 江苏众立生包装科技有限公司 2024-05-03 CN claimed
CN-117586497-A Preparation method of printing ink based on amino-terminated hyperbranched polyamide 江苏众立生包装科技有限公司 2024-02-23 CN claimed
CN-117586497-B Preparation method of printing ink based on amino-terminated hyperbranched polyamide 江苏众立生包装科技有限公司 2024-05-03 CN disclosed
CN-117586497-A Preparation method of printing ink based on amino-terminated hyperbranched polyamide 江苏众立生包装科技有限公司 2024-02-23 CN disclosed
US-8569516-B2 Compounds and methods for fluorescent labeling ELITECH HOLDING B.V. (NL) 2013-10-29 US disclosed
US-8569516-B2 Compounds and methods for fluorescent labeling ELITECH HOLDING B.V. (NL) 2013-10-29 US disclosed
US-8569516-B2 Compounds and methods for fluorescent labeling ELITECH HOLDING B.V. (NL) 2013-10-29 US disclosed
US-7601851-B2 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2009-10-13 US disclosed
US-7601851-B2 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2009-10-13 US disclosed
US-7601851-B2 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2009-10-13 US disclosed
EP-1991705-A4 COMPOUNDS AND METHODS FOR FLUORESCENT LABELING EPOCH BIOSCIENCES INC (US) 2009-07-01 EP disclosed
WO-2007098336-A2 COMPOUNDS AND METHODS FOR FLUORESCENT LABELING EPOCH BIOSCIENCES, INC. (US) 2007-08-30 WO disclosed
US-7112684-B2 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2006-09-26 US disclosed
US-20060204990-A1 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2006-09-14 US disclosed
US-20050277144-A1 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2005-12-15 US disclosed
US-6972339-B2 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2005-12-06 US disclosed
US-20050176066-A1 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2005-08-11 US disclosed
US-20050171340-A1 COMPOUNDS AND METHODS FOR FLUORESCENT LABELING EPOCH BIOSCIENCES, INC. (US) 2005-08-04 US disclosed
EP-1466176-A2 COMPOUNDS AND METHODS FOR FLUORESCENT LABELING Epoch Biosciences, Inc. (US) 2004-10-13 EP disclosed
WO-2003023357-A2 COMPOUNDS AND METHODS FOR FLUORESCENT LABELING EPOCH BIOSCIENCES, INC. (US) 2003-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176066-A1 Compounds and methods for fluorescent labeling HLCS, GLB1, TUBB KEAP1 1682/4885FFAR1 4582/4885GPR17 2551/4885
US-20060204990-A1 Compounds and methods for fluorescent labeling GLB1, HLCS, PFAS KEAP1 2485/4885FFAR1 4570/4885GPR17 2174/4885
US-20050171340-A1 COMPOUNDS AND METHODS FOR FLUORESCENT LABELING HLCS, GLB1, TUBB KEAP1 1682/4885FFAR1 4582/4885GPR17 2551/4885
US-20050277144-A1 Compounds and methods for fluorescent labeling HLCS, GLB1, TUBB KEAP1 1682/4885FFAR1 4582/4885GPR17 2551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.